OUR SERVICES

Regulatory Affairs, Drug Development, Pharmacovigilance, Medical Writing, Pricing & Reimbursement, Market Access

MORE

ABOUT US

Partner of many pharmaceutical companies, managing hundreds of multi-task projects, on a worldwide-scale

MORE

EVENTS

Discover next events

MORE
Jun
05
63° SIMPOSIO AFI Le Sfide dell’Industria della Salute: Ricerca, Innovazione, Sostenibilità Rimini, 5/7 Giugno 2024
MORE
Jun
05
2024
Jun
19
3° CONGRESSO NAZIONALE GIRF – GRUPPO ISPOR ROMA FOR FUTURE
MORE
Jun
19
2024

BLOG

ALL POSTS
May, 15 2024

EMA’S NEW GUIDELINES ON ENVIRONMENTA...

The European Medicines Agency (EMA) has recently published a significant update to its guideline on Environmental Risk Assessment ...

READ
May, 02 2024

The regulation of the Scientific-Economic ...

The regulation detailing the organization and functioning of the Scientific-Economic Commission of Pharmaceuticals (CSE) of the It...

READ
Apr, 15 2024

Transitioning to CTIS: Key Steps and Docum...

The transition of clinical trial applications from the Directive 2001/20/EC (CTD) to the Regulation EU No 536/2014 (CTR), facilita...

READ
RPN @regulatorypharmanet - JUN 4

CONTACT US

Our experts are available to help you with any question you might have








 
I accept THE PRIVACY POLICY